Tag Archives: HCV-TARGET

The University of Nebraska Medical Center is involved in an
international registry that’s evaluating new treatments for hepatitis C,
a disease that threatens many baby boomers.

UNMC,
a regional referral center for hepatitis C, is part of the Hepatitis C
Therapeutic Registry and Research Network, or HCV-TARGET. The network
will track thousands of patients over the next five years to monitor the
effectiveness and safety of new drugs to determine which ones are most
effective and can cure the disease most quickly with the fewest side
effects.

The network is made up of university and
community physicians at 103 sites in 31 states, Puerto Rico, Canada and
Europe, in partnership with the U.S. Food and Drug Administration.

Anyone being treated for the virus using newer medications is eligible to participate in the registry.

FDA, academia and industry team up to end hepatitis C

A research consortium known as the Hepatitis C Therapeutic Registry
and Research Network, or HCV-TARGET, has joined forces with the FDA to
share national data on how newly approved therapies for hepatitis C are
used and managed in routine practice. HCV-TARGET is led jointly by
investigators at the University of Florida and the University of North Carolina at Chapel Hill and is sponsored in part by multiple pharmaceutical companies.

The new partnership’s goal is to establish research collaborations
using the HCV-TARGET database to better inform patients and clinicians
about hepatitis C therapies.

The study is aimed at assessing the safety and immunogenicity of HCV prime-boost vaccinations ChAd3-hliNSmut and MVA-hliNSmut, administered intramuscularly in healthy volunteers and DAA treated patients. To read the entire study, click here Share This PageFollow Us … Continue reading → The post The study is aimed at assessing the safety and immunogenicity of HCV […]

The purpose of this study is to evaluate the efficacy and tolerability of DAA-based regimens in the clinical practice in HIV/HCV-coinfected patients. Hypothesis: The efficacy and tolerability of all DAA-based regimens in the clinical practice is different to what is … Continue reading → The post Real-life Security and Efficacy of DAA-based Therapy in 1,000 […]